P147 IMPLEMENTATION OF A NEW ORAL CONTRAST AGENT FOR CT AND MR ENTEROGRAPHY IN PEDIATRIC IBD CLINICAL PRACTICE: IMPACT ON TOLERABILITY, DISTENSION, IMAGE QUALITY AND DIAGNOSTIC CONFIDENCE

To evaluate the ability of pediatric patients with suspected IBD to ingest a new oral contrast agent at CT or MR enterography (CTE/MRE) and to determine the impact on small bowel (SB) distension and diagnostic confidence.